Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Shares Outstanding (Diluted Average) (2016 - 2025)

Xtant Medical Holdings has reported Shares Outstanding (Diluted Average) over the past 16 years, most recently at $150.0 million for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 12.25% to $150.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $150.0 million through Dec 2025, up 12.25% year-over-year, with the annual reading at $150.0 million for FY2025, 12.25% up from the prior year.
  • Shares Outstanding (Diluted Average) was $150.0 million for Q4 2025 at Xtant Medical Holdings, roughly flat from $149.9 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $150.0 million in Q4 2025 and troughed at $81.2 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Diluted Average) is $117.8 million (2023), against an average of $114.7 million.
  • Year-over-year, Shares Outstanding (Diluted Average) surged 556.78% in 2021 and then fell 2.79% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $85.5 million in 2021, then grew by 10.1% to $94.1 million in 2022, then soared by 34.76% to $126.8 million in 2023, then grew by 5.42% to $133.7 million in 2024, then rose by 12.25% to $150.0 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Shares Outstanding (Diluted Average) are $150.0 million (Q4 2025), $149.9 million (Q3 2025), and $148.6 million (Q2 2025).